Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
European School of Oncology
Aug 7, 2024, 16:50 |
Blog
The recipients of the 2024 ESMO Society Awards
The 2024 ESMO Society Awards have been announced on 6th August by ESMO. ESMO recently…
Aug 7, 2024, 07:35 |
Blog
Pushing the boundaries of cancer care - ESTRO
ESTRO (European Society for Radiotherapy and Oncology) shared a post on LinkedIn: ''MRO.34: Modern Oncology…
Aug 1, 2024, 17:11 |
Blog
Dr. Igor Aurer: Updated Guidelines and Insights on HIV-Related Lymphoma Treatment - MediaMedic
MediaMedic posted on LinkedIn: "Patients with AIDS have a significantly higher risk of developing non-Hodgkin…
Jul 31, 2024, 07:20 |
Blog
Blended course on MR-linac Radiotherapy by ESTRO
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "Exciting Opportunity for Radiation Therapy…
Jul 30, 2024, 07:55 |
Societies
FASCO Recipients for this quarter - Part 1
FASCO Recipients - Part 1 ASCO recently shared on X: "Join us in congratulating our…
Jul 24, 2024, 06:16 |
Blog
Shushan Hovsepyan: Five open grant opportunities for pediatric oncologists
Shushan Hovsepyan shared a post on LinkedIn: ''Five open grant opportunities for pediatric oncologists! Check…
Jul 24, 2024, 00:54 |
Blog
12 leaders selected for the 2024-2025 ASCO Leadership Development Program
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "We congratulate the 12…
Jul 22, 2024, 02:26 |
Insight
New Chapter in Ewing Sarcoma Treatment - The story of TK216
Shushan Hovsepyan shared a post on LinkedIn about a recent paper by Paul Meyers et…
Jul 21, 2024, 15:58 |
Blog
Shushan Hovsepyan: Highlights from the ARST1431 study about treatment outcomes of RMS patients
Shushan Hovsepyan shared a post on LinkedIn: ''How can we better use molecular insights to…
Jul 21, 2024, 12:10 |
Blog
invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma
invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…
15
16
17
18
19
All:
270
Posts:
161 - 170
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Facebook
RSS Feed
Twitter
Linkedin
Youtube